Adegbenga A. Bankole MD FACP, FACR

Lupus & Related

Professor of Medicine Virginia Tech Carilion School of Medicine (VTCSOM) Program Director: Rheumatology fellowship program Division Chief: Division Rheumatology

Join to View Full Profile

3 Riverside CircleRoanoke, VA 24016
Phone+1 540-981-7700

Summary

Dr. Adegbenga Bankole is a rheumatologist in Roanoke, VA and is affiliated with Carilion Roanoke Memorial Hospital. He received his medical degree from University of Ibadan and has been in practice 19 years. He specializes in lupus & related and is experienced in systemic lupus erythematosus and osteoporosis. He has more than 10 publications and over 150 citings.

Education & Training

SUNY Downstate Health Sciences UniversityFellowship, Rheumatology, 2007 - 2009
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2004 - 2007
University of IbadanClass of 1998

Certifications & Licensure

VA State Medical License 2009 - 2026
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Leonard Tow Humanism in Medicine Award The Arnold Gold Foundation, 2023
Gold Humanism Honor Society Virginia tech carilion school of medicine, 2022
Fellow American College of Physicians, 2015
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) Start of enrollment: 2023 Jan 12
RECRUITING
PHASE3
A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) Start of enrollment: 2019 Jul 25
Completed
Phase 2
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis Start of enrollment: 2019 Feb 06
COMPLETED
PHASE3
A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State Start of enrollment: 2020 Jul 27
COMPLETED
PHASE2
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus Start of enrollment: 2023 Jul 19
RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

The cardiovascular effects of interleukin-6 inhibition in patients with severe coronavirus-19 infection.
Michael S Binder, Clinton Timmerman, Biwar Marof, Yingxing Wu, Adegbenga Bankole
The Journal of International Medical Research. 2025-04-01
A review of neonatal lupus syndrome.
Adegbenga Bankole, Jane Nwaonu
Science Progress. 2024-09-17
A case of immune mediated necrotizing myositis.
Viraj Shah, Lena Young, Hyder Husain, Taskeen Kazmi, Adegbenga Bankole
The American Journal of the Medical Sciences. 2023-09-01

Journal Articles

The cardiovascular effects of interleukin-6 inhibition in patients with severe coronavirus-19 infection.
Binder MS, Timmerman C, Marof B, Wu Y, Bankole A, Heletz I., infection. Journal of International Medical Research., 4/2/2025